Answers are grounded in this paper and cite their sources.
AMA Durajczyk M, Seredyńska K, Lubiński W. Macular abnormalities in retinitis pigmentosa. Management and treatment. Klinika Oczna / Acta Ophthalmologica Polonica. 2024. doi:10.5114/ko.2024.139668. APA Durajczyk, M., Seredyńska, K., & Lubiński, W. (2024). Macular abnormalities in retinitis pigmentosa. Management and treatment. Klinika Oczna / Acta Ophthalmologica Polonica. https://doi.org/10.5114/ko.2024.139668 Chicago Durajczyk, Magdalena, Katarzyna Seredyńska, and Wojciech Lubiński. 2024. "Macular abnormalities in retinitis pigmentosa. Management and treatment". Klinika Oczna / Acta Ophthalmologica Polonica. doi:10.5114/ko.2024.139668. Harvard Durajczyk, M., Seredyńska, K., and Lubiński, W. (2024). Macular abnormalities in retinitis pigmentosa. Management and treatment. Klinika Oczna / Acta Ophthalmologica Polonica. https://doi.org/10.5114/ko.2024.139668 MLA Durajczyk, Magdalena et al. "Macular abnormalities in retinitis pigmentosa. Management and treatment." Klinika Oczna / Acta Ophthalmologica Polonica, 2024. doi:10.5114/ko.2024.139668. Vancouver Durajczyk M, Seredyńska K, Lubiński W. Macular abnormalities in retinitis pigmentosa. Management and treatment. Klinika Oczna / Acta Ophthalmologica Polonica. 2024. doi:10.5114/ko.2024.139668.
No takes yet. Share an insight, caveat, or question.
Durajczyk et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: